Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Late complications after cardiac transplantation.

Literature DB >> 8068477

Late complications after cardiac transplantation.

B P Madden¹.

Abstract

Mesh：

Substances：
Cyclosporine

Year: 1994 PMID： 8068477 PMCID： PMC1025432 DOI： 10.1136/hrt.72.1.89

Source DB: PubMed Journal: Br Heart J ISSN： 0007-0769

× No keyword cloud information.

15 in total

1. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors: T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal: Lancet Date: 1984-03-17 Impact factor: 79.321

2. The medical management of patients with cystic fibrosis following heart-lung transplantation.

Authors: B P Madden; K Kamalvand; C M Chan; A Khaghani; M E Hodson; M Yacoub
Journal: Eur Respir J Date: 1993-07 Impact factor: 16.671

3. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

Authors: D W Hanto; G Frizzera; K J Gajl-Peczalska; K Sakamoto; D T Purtilo; H H Balfour; R L Simmons; J S Najarian
Journal: N Engl J Med Date: 1982-04-15 Impact factor: 91.245

4. The importance of cytomegalovirus in heart-lung transplant recipients.

Authors: J A Hutter; J Scott; T Wreghitt; T Higenbottam; J Wallwork
Journal: Chest Date: 1989-03 Impact factor: 9.410

5. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

Authors: M A Nalesnik; R Jaffe; T E Starzl; A J Demetris; K Porter; J A Burnham; L Makowka; M Ho; J Locker
Journal: Am J Pathol Date: 1988-10 Impact factor: 4.307

Late complications after cardiac transplantation.

1. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

2. The medical management of patients with cystic fibrosis following heart-lung transplantation.

3. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

4. The importance of cytomegalovirus in heart-lung transplant recipients.

5. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

6. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection.

7. Cyclosporine-associated chronic nephropathy.

Review 8. Cyclosporine: a new immunosuppressive agent for organ transplantation.

9. Disseminated toxoplasmosis in cardiac transplantation.

10. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine.

Review 1. Viral prophylaxis in organ transplant patients.